{
  "plain_title": "What are the effects of medicines in treating gastro-oesophageal reflux (a condition where stomach acid flows back into the throat) in children?",
  "key_messages": [
    "The effects of medicines in treating gastro-oesophageal reflux (a condition where stomach acid flows back into the throat) in children are not clearly understood, and there is no strong evidence to support the use of specific medications, including omeprazole, esomeprazole, and proton pump inhibitors (medicines that reduce stomach acid production), due to a lack of robust evidence.",
    "Medicines may or may not provide a benefit for infants and children with gastro-oesophageal reflux disease (GORD), a condition where gastro-oesophageal reflux causes symptoms severe enough to merit treatment, and further research is needed to determine their effectiveness.",
    "Future studies should investigate the long-term effects of these medications and their potential benefits and harms in different subgroups of children, such as preterm babies and children with neurodisabilities, to provide more accurate and reliable information for decision-making."
  ],
  "background": [
    {
      "subheading": "What is gastro‐oesophageal reflux in children?",
      "content": "Gastro‐oesophageal reflux (GOR) is a condition where the stomach contents flow back up into the oesophagus, causing symptoms such as regurgitation. It is a common problem in infants, affecting approximately 50% of those under three months old, and can also occur in older children. While GOR often improves with age, some children may experience more persistent symptoms, particularly if they have other medical conditions."
    },
    {
      "subheading": "Why is gastro‐oesophageal reflux a problem?",
      "content": "GOR can be a self-limiting condition, but for some children, it can lead to more severe symptoms and complications. The distinction between GOR and gastro‐oesophageal reflux disease (GORD) is important, as GORD is defined as GOR that causes symptoms severe enough to require treatment. Current guidelines from the National Institute of Health and Care Excellence (NICE) emphasize the need for effective management of GORD."
    },
    {
      "subheading": "What are the common treatments for gastro‐oesophageal reflux in children?",
      "content": "Pharmacological treatments, such as proton pump inhibitors (PPIs) and H₂ antagonists, are often used to manage GOR in children. However, the effectiveness of these treatments can vary, and there is a need to assess their benefits and potential harms."
    },
    {
      "subheading": "What did the review authors want to find out?",
      "content": "The review authors aimed to assess the effects of pharmacological treatments for GOR in infants and children. They wanted to determine which treatments are most effective in improving symptoms and reducing the risk of complications, and to identify any potential harms associated with these treatments."
    }
  ],
  "methods": [
    {
      "subheading": "Methods",
      "content": "We searched for studies comparing pharmacological treatments for gastro-oesophageal reflux in children, summarized their results, and rated our confidence in the evidence."
    }
  ],
  "results": [
    {
      "subheading": "What did we find?",
      "content": "We found 36 studies that involved 2251 children and infants with gastro-oesophageal reflux. The studies were conducted in various countries around the world, although the specific locations were not detailed. Most studies lasted for around two weeks, with some lasting up to several months. The funding sources for the studies were not explicitly stated. The population characteristics included infants up to 12 months old and children aged 12 months to 16 years old, with some studies focusing on specific age groups such as neonates. The study settings were not explicitly stated, but it can be inferred that they took place in primary and secondary care settings. The types of interventions and comparisons included pharmacological treatments such as omeprazole, esomeprazole, ranitidine, and proton pump inhibitors, compared to placebo or other medications. Unfortunately, there were insufficient summary data to assess other medications, and further studies with longer follow-up are needed, particularly in subgroups such as preterm babies and children with neurodisabilities. The review found that medications may or may not provide a benefit for infants with gastro-oesophageal reflux, and there is no clear evidence to support the use of specific medications such as omeprazole, esomeprazole, or proton pump inhibitors. In older children, proton pump inhibitors may or may not improve symptoms, but the evidence is uncertain. Further studies are needed to determine the effectiveness of these medications."
    }
  ],
  "limitations": "The evidence is limited because the studies were very small and do not cover all of the people, interventions, comparators, and outcomes of interest.",
  "currency": "This review updates our previous review. The evidence is up to date to September 2022."
}